Mefloquine for preventing malaria in pregnant women

  • Raquel González
  • , Ragna S. Boerma
  • , David Sinclair
  • , John J. Aponte
  • , Feiko Ter Kuile
  • , Clara Menéndez

Research output: Contribution to journalArticlepeer-review

40 Citations (Scopus)

Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

To assess the effects of mefloquine for preventing malaria in pregnant women. Specifically, to evaluate the:

•efficacy, safety and tolerability of mefloquine for preventing malaria in pregnant women.

•effect of HIV status, gravidity and ITN use on mefloquine efficacy.

Original languageEnglish
Article numberCD011444
Pages (from-to)CD011444
JournalCochrane Database of Systematic Reviews
Volume2015
Issue number1
DOIs
Publication statusPublished - 14 Jan 2015

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Mefloquine for preventing malaria in pregnant women'. Together they form a unique fingerprint.

Cite this